Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster DTPw-HBV/Hib Vaccine in Primed Infants
NCT00158808Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2005
- Primary completion
- Apr 2005
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of DTwP-HepB-Hib vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Jan 2005; status: completed.
02
Drugs
DTwP-HepB-Hib vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00158808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158808.